Amgen Inc. (AMGN) Covered Calls
Amgen Inc. is an independent biotechnology medicines company. It discovers, develops, manufactures and markets medicines for grievous illnesses.
You can sell covered calls on Amgen Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for AMGN (prices last updated Fri 4:16 PM ET):
| Amgen Inc. (AMGN) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 272.11 | +2.68 | 272.46 | 272.98 | 3.1M | 35 | 145 |
| Covered Calls For Amgen Inc. (AMGN) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Feb 21 | 270 | 9.10 | 263.88 | 3.2% | 32.4% | |
| Mar 21 | 270 | 10.20 | 262.78 | 3.7% | 21.1% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. Its products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
| Top 10 Open Interest For Feb 21 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | FXI covered calls | 1. | RGTI covered calls | |
| 2. | TLT covered calls | 7. | TSLA covered calls | 2. | QUBT covered calls | |
| 3. | IWM covered calls | 8. | AMZN covered calls | 3. | DJT covered calls | |
| 4. | SPY covered calls | 9. | ASHR covered calls | 4. | MSTR covered calls | |
| 5. | SLV covered calls | 10. | AAPL covered calls | 5. | SOUN covered calls | |
Want more examples? AMG Covered Calls | AMH Covered Calls
